Literature DB >> 12791594

Age and attenuation of exercise-induced myocardial HSP72 accumulation.

Haydar A Demirel1, Karyn L Hamilton, R Andrew Shanely, Nihal Tümer, Mary Jo Koroly, Scott K Powers.   

Abstract

Overexpression of heat shock protein (HSP)72 is associated with cardioprotection. Hyperthermia-induced HSP72 overexpression is attenuated with senescence. While exercise also increases myocardial HSP72 in young animals, it is unknown whether this effect is attenuated with aging. Therefore, we investigated the effect of aging on exercise-induced myocardial heat shock factor (HSF)-1 activation and HSP72 expression. Male Fischer-344 rats (6 or 24 mo) were randomized to control, exercise, and hyperthermic groups. Exercise consisted of 2 days of treadmill running (60 min/day, approximately 75% maximal oxygen consumption). Hyperthermia, 15 min at approximately 41 degrees C (colonic temperature), was achieved using a temperature-controlled heating blanket. Analyses included Western blotting for myocardial HSP72 and HSF-1, electromobility shift assays for HSF-1 activation, and Northern blotting for HSP72 mRNA. Exercise and hyperthermia increased (P < 0.05) myocardial HSP72 in both young (>3.5- and 2.5-fold, respectively) and aged (>3- and 1.5-fold, respectively) animals. Both exercise and hyperthermic induction of HSP72 was attenuated with age. Myocardial HSF-1 protein, HSF-1 activation, and HSP72 mRNA did not differ with age. These data demonstrate that aging is associated with diminished exercise-induced myocardial HSP72 expression. Mechanisms other than HSF-1 activation and transcription of HSP72 mRNA are responsible for this age-related impairment.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12791594     DOI: 10.1152/ajpheart.00982.2002

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  18 in total

Review 1.  Heat shock proteins as emerging therapeutic targets.

Authors:  Csaba Sõti; Enikõ Nagy; Zoltán Giricz; László Vígh; Péter Csermely; Péter Ferdinandy
Journal:  Br J Pharmacol       Date:  2005-11       Impact factor: 8.739

Review 2.  Mechanisms of exercise-induced cardioprotection.

Authors:  Scott K Powers; Ashley J Smuder; Andreas N Kavazis; John C Quindry
Journal:  Physiology (Bethesda)       Date:  2014-01

Review 3.  The exercise-induced stress response of skeletal muscle, with specific emphasis on humans.

Authors:  James P Morton; Anna C Kayani; Anne McArdle; Barry Drust
Journal:  Sports Med       Date:  2009       Impact factor: 11.136

Review 4.  Mitochondrial therapeutics for cardioprotection.

Authors:  Raquel S Carreira; Pamela Lee; Roberta A Gottlieb
Journal:  Curr Pharm Des       Date:  2011       Impact factor: 3.116

Review 5.  Oxygen consumption and usage during physical exercise: the balance between oxidative stress and ROS-dependent adaptive signaling.

Authors:  Zsolt Radak; Zhongfu Zhao; Erika Koltai; Hideki Ohno; Mustafa Atalay
Journal:  Antioxid Redox Signal       Date:  2012-11-16       Impact factor: 8.401

6.  Endurance training accelerates exhaustive exercise-induced mitochondrial DNA deletion and apoptosis of left ventricle myocardium in rats.

Authors:  Chi-Chang Huang; Tien-Jen Lin; Chun-Chieh Chen; Wan-Teng Lin
Journal:  Eur J Appl Physiol       Date:  2009-12       Impact factor: 3.078

Review 7.  Estrogen and the female heart.

Authors:  A A Knowlton; D H Korzick
Journal:  Mol Cell Endocrinol       Date:  2014-01-22       Impact factor: 4.102

Review 8.  Mitochondria in the middle: exercise preconditioning protection of striated muscle.

Authors:  John M Lawler; Dinah A Rodriguez; Jeffrey M Hord
Journal:  J Physiol       Date:  2016-09-15       Impact factor: 5.182

Review 9.  Estrogen, aging and the cardiovascular system.

Authors:  James P Stice; Jennifer S Lee; Angela S Pechenino; Anne A Knowlton
Journal:  Future Cardiol       Date:  2009-01

10.  Peripheral venous occlusion causing cardiac hypertrophy and changes in biological parameters in rats.

Authors:  Shigeo Kawada; Naokata Ishii
Journal:  Eur J Appl Physiol       Date:  2009-01-06       Impact factor: 3.078

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.